Henry Schein, Inc. (NASDAQ:HSIC) Receives $76.08 Average Price Target from Analysts

Henry Schein, Inc. (NASDAQ:HSIC) has earned a consensus rating of “Hold” from the thirteen brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $76.1667.

Several analysts have recently commented on HSIC shares. Morgan Stanley increased their price objective on Henry Schein from $55.00 to $58.00 and gave the company an “underweight” rating in a report on Wednesday, November 5th. Wells Fargo & Company raised their price target on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 5th. Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Evercore ISI lifted their target price on shares of Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 5th. Finally, Barrington Research set a $79.00 target price on shares of Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday, November 5th.

Henry Schein Stock Performance

HSIC stock opened at $73.34 on Tuesday. Henry Schein has a one year low of $60.56 and a one year high of $82.49. The firm has a market cap of $8.63 billion, a price-to-earnings ratio of 23.21, a PEG ratio of 2.23 and a beta of 0.89. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.79 and a current ratio of 1.40. The firm has a 50-day simple moving average of $68.14 and a two-hundred day simple moving average of $69.46.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 EPS for the quarter, topping the consensus estimate of $1.27 by $0.11. The firm had revenue of $3.34 billion during the quarter, compared to analyst estimates of $3.28 billion. Henry Schein had a net margin of 3.02% and a return on equity of 14.76%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, equities analysts forecast that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Trading of Henry Schein

A number of institutional investors and hedge funds have recently modified their holdings of HSIC. Ameriprise Financial Inc. increased its stake in Henry Schein by 3,275.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company’s stock worth $165,594,000 after buying an additional 2,199,695 shares in the last quarter. Norges Bank acquired a new stake in shares of Henry Schein in the second quarter worth approximately $89,476,000. M.D. Sass LLC acquired a new stake in shares of Henry Schein in the second quarter worth approximately $79,201,000. Schroder Investment Management Group increased its position in shares of Henry Schein by 149.3% during the second quarter. Schroder Investment Management Group now owns 1,563,899 shares of the company’s stock worth $114,243,000 after purchasing an additional 936,471 shares in the last quarter. Finally, Bank of America Corp DE raised its stake in Henry Schein by 204.2% in the 2nd quarter. Bank of America Corp DE now owns 995,375 shares of the company’s stock valued at $72,712,000 after purchasing an additional 668,182 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.